US Stock MarketDetailed Quotes

COCP Cocrystal Pharma

Watchlist
  • 2.2600
  • -0.0100-0.44%
Close Jul 17 16:00 ET
22.99MMarket Cap-1395P/E (TTM)

Cocrystal Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-18.65%4.16M
16.66%21.16M
25.86%5.67M
6.13%6.04M
16.14%4.34M
21.55%5.11M
27.54%18.14M
21.61%4.5M
44.04%5.69M
-2.40%3.74M
Selling and administrative expenses
0.33%1.21M
4.26%5.99M
15.14%1.4M
1.48%1.85M
11.85%1.54M
-9.68%1.2M
5.86%5.75M
25.39%1.22M
-1.41%1.82M
8.18%1.38M
-General and administrative expense
0.33%1.21M
4.26%5.99M
15.14%1.4M
1.48%1.85M
11.85%1.54M
-9.68%1.2M
5.86%5.75M
25.39%1.22M
-1.41%1.82M
8.18%1.38M
Research and development costs
-24.49%2.95M
22.41%15.17M
29.81%4.27M
8.32%4.19M
18.64%2.8M
36.04%3.91M
40.91%12.39M
20.27%3.29M
83.94%3.87M
-7.67%2.36M
Operating profit
18.65%-4.16M
-16.66%-21.16M
-25.86%-5.67M
-6.13%-6.04M
-16.14%-4.34M
-21.55%-5.11M
-27.54%-18.14M
-21.61%-4.5M
-44.04%-5.69M
2.40%-3.74M
Net non-operating interest income expense
220K
32,100.00%640K
180K
32,100.00%320K
140K
0
50.00%-2K
0
0.00%-1K
0
Total other finance cost
---220K
-32,100.00%-640K
---180K
-32,100.00%-320K
---140K
----
--2K
--0
--1K
----
Other net income (expense)
76.92%-18K
112.25%2.54M
102,100.00%1.02M
31,260.00%1.56M
100.16%33K
-3,800.00%-78K
-51,845.00%-20.7M
-94.12%1K
-138.46%-5K
-230,011.11%-20.69M
Gain on sale of security
76.92%-18K
-983.33%-65K
2,100.00%22K
-740.00%-42K
--33K
-3,800.00%-78K
-115.00%-6K
-94.12%1K
-138.46%-5K
----
Special income (charges)
----
112.57%2.6M
--1M
--1.6M
--0
----
---20.69M
--0
--0
---20.69M
-Less:Impairment of capital assets
----
--0
--0
--0
--0
----
--19.09M
--0
--0
--19.09M
-Less:Other special charges
----
-262.50%-2.6M
---1M
---1.6M
----
----
--1.6M
--0
----
--1.6M
Income before tax
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
-539.31%-24.43M
Income tax
Net income
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
-539.31%-24.43M
Net income continuous Operations
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
-539.31%-24.43M
Minority interest income
Net income attributable to the parent company
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
-539.31%-24.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
-539.31%-24.43M
Basic earnings per share
39.06%-0.39
60.80%-1.87
18.52%-0.44
41.43%-0.41
86.33%-0.41
-23.08%-0.64
-2,881.25%-4.77
-142.19%-0.54
-45.83%-0.7
-525.00%-3
Diluted earnings per share
39.06%-0.39
60.80%-1.87
18.52%-0.44
41.43%-0.41
86.33%-0.41
-23.08%-0.64
-2,881.25%-4.77
-142.19%-0.54
-45.83%-0.7
-525.00%-3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -18.65%4.16M16.66%21.16M25.86%5.67M6.13%6.04M16.14%4.34M21.55%5.11M27.54%18.14M21.61%4.5M44.04%5.69M-2.40%3.74M
Selling and administrative expenses 0.33%1.21M4.26%5.99M15.14%1.4M1.48%1.85M11.85%1.54M-9.68%1.2M5.86%5.75M25.39%1.22M-1.41%1.82M8.18%1.38M
-General and administrative expense 0.33%1.21M4.26%5.99M15.14%1.4M1.48%1.85M11.85%1.54M-9.68%1.2M5.86%5.75M25.39%1.22M-1.41%1.82M8.18%1.38M
Research and development costs -24.49%2.95M22.41%15.17M29.81%4.27M8.32%4.19M18.64%2.8M36.04%3.91M40.91%12.39M20.27%3.29M83.94%3.87M-7.67%2.36M
Operating profit 18.65%-4.16M-16.66%-21.16M-25.86%-5.67M-6.13%-6.04M-16.14%-4.34M-21.55%-5.11M-27.54%-18.14M-21.61%-4.5M-44.04%-5.69M2.40%-3.74M
Net non-operating interest income expense 220K32,100.00%640K180K32,100.00%320K140K050.00%-2K00.00%-1K0
Total other finance cost ---220K-32,100.00%-640K---180K-32,100.00%-320K---140K------2K--0--1K----
Other net income (expense) 76.92%-18K112.25%2.54M102,100.00%1.02M31,260.00%1.56M100.16%33K-3,800.00%-78K-51,845.00%-20.7M-94.12%1K-138.46%-5K-230,011.11%-20.69M
Gain on sale of security 76.92%-18K-983.33%-65K2,100.00%22K-740.00%-42K--33K-3,800.00%-78K-115.00%-6K-94.12%1K-138.46%-5K----
Special income (charges) ----112.57%2.6M--1M--1.6M--0-------20.69M--0--0---20.69M
-Less:Impairment of capital assets ------0--0--0--0------19.09M--0--0--19.09M
-Less:Other special charges -----262.50%-2.6M---1M---1.6M----------1.6M--0------1.6M
Income before tax 23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M-539.31%-24.43M
Income tax
Net income 23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M-539.31%-24.43M
Net income continuous Operations 23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M-539.31%-24.43M
Minority interest income
Net income attributable to the parent company 23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M-539.31%-24.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M-539.31%-24.43M
Basic earnings per share 39.06%-0.3960.80%-1.8718.52%-0.4441.43%-0.4186.33%-0.41-23.08%-0.64-2,881.25%-4.77-142.19%-0.54-45.83%-0.7-525.00%-3
Diluted earnings per share 39.06%-0.3960.80%-1.8718.52%-0.4441.43%-0.4186.33%-0.41-23.08%-0.64-2,881.25%-4.77-142.19%-0.54-45.83%-0.7-525.00%-3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg